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Reduced WIF-1 Expression Stimulates Skin
Hyperpigmentation in Patients with Melasma
Ji-Young Kim1, Tae-Ryong Lee2 and Ai-Young Lee1
The expression of Wnt inhibitory factor-1 (WIF-1) gene, which was detected by a microarray analysis of
hyperpigmented and normally pigmented skin sets of melasma patients, was significantly reduced in the
hyperpigmented skin from melasma patients, but not in healthy controls, regardless of UV irradiation. Wnt
signals regulate skin pigmentation; however, WIF-1 is expressed in cultured skin keratinocytes and
fibroblasts, but not in melanocytes. Therefore, we examined whether WIF-1 knockdown in neighboring
keratinocytes and fibroblasts plays a role in melasma. Additionally, the effect of WIF-1 overexpression on
the amelioration of hyperpigmentation was examined. WIF-1 knockdown, either in fibroblasts or in
keratinocytes, significantly stimulated tyrosinase expression and melanosome transfer, whereas melano-
cytes with WIF-1 overexpression significantly reduced those parameters. The WIF-1 knockdown decreased
glycogen synthase kinase-3b (GSK-3b), b-catenin, and NFATc2 (nuclear factor of activated T cells, cytoplasmic,
calcineurin-dependent 2) phosphorylation and increased microphthalmia-associated transcription factor
(MITF) expression as in melanocytes with Wnt-1 overexpression, whereas the WIF-1 overexpression
reversed the results. Expression of Wnts, both canonical and noncanonical, was increased in the
hyperpigmented skin of melasma patients. Collectively, WIF-1 downregulation, which may occur in
epidermal keratinocytes and in dermal fibroblasts, is involved in melasma development because of the
stimulation of melanogenesis and melanosome transfer through upregulation of the canonical and the
noncanonical Wnt signaling pathway.
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INTRODUCTION
Melasma is one of the most common patterns of hyperpig-
mentation that affects skin on the upper lip, cheeks, forehead,
and chin, particularly during the reproductive lifespan of
women. In terms of pigmentation, melasma does not differ
from other conditions with hyperpigmentation; however, the
outcome is different from the hyperpigmentation caused by
inflammation or by UV exposure. If regulatory mechanisms,
which are involved in melanogenesis of these conditions,
do not differ, then their outcome should not be different.
Recently, we performed microarray analysis to compare
hyperpigmented with normally pigmented skin specimens
from patients with melasma to identify specific factors
associated with the hyperpigmentation of melasma. Down-
regulation of H19 RNA was one of the identified factors
associated with melasma (Kim et al., 2010a, b). There was
also a X2-fold downregulation in the expression of the Wnt
inhibitory factor-1 (WIF-1) gene in the hyperpigmented skin
of melasma patients (data not shown).
Wnts, a family of secreted glycoproteins, regulate a vast
array of biological processes, including embryonic develop-
ment, cell fate, cell proliferation, cell migration, stem cell
maintenance, tumor suppression, and oncogenesis. In terms
of pigmentation, Wnt signals have been shown to be involved
in directing neural crest cells to adopt pigment cell fates
(Dorsky et al., 1998) and in pigment cell differentiation
(Dorsky et al., 2000), through either the canonical (Yama-
guchi et al., 2008) or the noncanonical pathways (Kim et al.,
2010a, b). In the canonical pathway, b-catenin plays a critical
role, which is also called the Wnt/b-catenin pathway (Miller
et al., 1999); without the binding of canonical Wnts, such as
Wnt-1, Wnt-3A, and Wnt-8, b-catenin is degraded by the
destruction complex while keeping the levels of free b-
catenin low. The destruction complex is composed of four
proteins, and glycogen synthase kinase-3 (GSK-3) is the
central player with phosphorylation of b-catenin (Yost et al.,
1996). With the binding to their receptor, Frizzled, these
canonical Wnts prevent the degradation, which leads to a
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generation of a signaling pool of b-catenin, and translocate
b-catenin to the nucleus. Thereby, it forms a complex with
the lymphocyte enhancer-binding factor 1/T-cell factor
transcription factors (Eastman and Grosschedl, 1999; Novak
and Dedhar, 1999) to stimulate transcription of target genes.
In addition, microphthalmia-associated transcription factor
(MITF) interacts with b-catenin to activate gene expression
(Schepsky et al., 2006). On the other hand, noncanonical
Wnt pathway is b-catenin independent and involves a diverse
signal transduction, such as calcium flux, which is called the
Wnt/calcium pathway, or c-Jun N-terminal kinase (JNK). In
the Wnt/calcium pathway, noncanonical Wnts, such as Wnt-
4, Wnt-5A, and Wnt-11, activate calcium-sensitive kinase,
protein kinase C (PKC) (Sheldahl et al., 1999), and calcium-
responsive transcription factor, which is the nuclear factor of
activated T cells (NFAT) (Murphy and Hughes, 2002;
Saneyoshi et al., 2002).
The extracellular antagonists of the Wnt signaling pathway
can be divided into two classes (Kawano and Kypta, 2003).
WIF-1, which is a secreted antagonist of Wnt signaling (Hsieh
et al., 1999), belongs to the secreted Frizzled-related protein
(sFRP) class, which binds directly to Wnts in the extracellular
space, along with the sFRP family. The Dickkopf class
antagonists include the member of certain Dickkopf family,
which inhibit Wnt signaling by binding to the low-density-
lipoprotein-receptor-related protein 5 and 6 component of the
Wnt receptor complex. Antagonists of the sFRP class have been
considered to inhibit both canonical and noncanonical Wnt
pathways, whereas those of the Dickkopf class inhibit only the
canonical Wnt pathway, despite many of the unresolved issues.
Although Wnt signals regulate skin pigmentation, the
expression of WIF-1 has not been previously reported in
melanocytes. On the other hand, WIF-1 expression has been
found in keratinocytes (Sasahara et al., 2009; Gudjonsson
et al., 2010) and in fibroblasts (Cho et al., 2009). Melanocyte
growth and differentiation is affected by neighboring fibro-
blasts (Yamaguchi et al., 2004) as well as by keratinocytes,
and in this study we show an association between down-
regulation of the WIF-1 gene in those neighboring skin cells
and melasma along with its function at the molecular level.
As the functional significance of WIF-1 downregulation in
cancers has been identified with WIF-1 upregulation (Elston
et al., 2008; Kawakami et al., 2009; Rubin et al., 2010; Yee
et al., 2010), we used that approach to demonstrate that the
upregulation of WIF-1 using recombinant human WIF-1
reduces pigmentation.
RESULTS
WIF-1 expression in the skin of patients with melasma
Levels of WIF-1 mRNA expression were analyzed using real-
time PCR in both hyperpigmented and normally pigmented
skin specimens biopsied from 13 patients with melasma.
Levels of WIF-1 mRNA in the hyperpigmented skin were
significantly (Po0.001) lower than in the normally pigmen-
ted skin (Figure 1a). However, the WIF-1 mRNA levels did
not reduce in the lateral cheeks or the forehead skin
compared with the postauricular skin from the three normal
individuals (Figure 1b). Additionally, no decrease in the
WIF-1 mRNA was observed at UV-induced hyperpigmented
compared with nonexposed control skin from the abdomen
of three normal individuals (Figure 1c). Double staining with
antibodies to WIF-1 and cytokeratin 14 (K14; a keratinocyte
marker), which was performed in 7 of 13 patients, suggested
in all cases weaker staining of WIF-1 in the epidermal
keratinocytes and in the cells that are scattered in the dermis
of the hyperpigmented when compared with the normally
pigmented skin specimens (Figure 1d).
WIF-1 expression in cultured skin cells
Immunohistochemistry suggested that the expression of
WIF-1 decreased in both keratinocytes and dermal cells.
Melanocyte growth and differentiation is affected by neigh-
boring keratinocytes and fibroblasts (Yamaguchi et al., 2004).
Therefore, expression of WIF-1 was examined not only in
melanocytes, but also in keratinocytes and in fibroblasts
cultured from normal human skin. The expression of WIF-1
mRNA and protein was detected in both keratinocytes and
fibroblasts, but not in melanocytes regardless of 12-O-
tetradecanoylphorbol-13-acetate treatment (Figure 2a and b).
Effect of WIF-1 downregulation in keratinocytes on
hyperpigmentation
After identifying that transfection of WIF-1 small interfering
RNA (siRNA) significantly (Po0.001) reduced the levels of
bothWIF-1 mRNA and protein expression in cultured normal
keratinocytes (Figure 3a), their effect was examined in
keratinocyte/melanocyte co-cultures, without the purification
of melanocytes. The decreased expression of WIF-1
in the keratinocytes significantly (Po0.005) stimulated
tyrosinase expression (Figure 3b). Concerning the signaling
pathways, the WIF-1 knockdown significantly (Po0.05)
decreased the phosphorylation of GSK-3b and b-catenin,
with increased MITF expression. The knockdown also
reduced the phosphorylation of NFAT, cytoplasmic, calci-
neurin-dependent 2 (NFATc2) (Figure 3c). As NFATc2 and
b-catenin require to translocate to the nucleus to exert their
action, western blot analysis of NFATc2 and b-catenin
expression performed in nuclear fraction suggested a
significant (Po0.05) increase by the WIF-1 knockdown
(Figure 3d). The WIF-1 knockdown also significantly
(Po0.05) increased the proportion of tyrosinase-related
protein-1 (TYRP-1) and K14 double-positive cells, which
was shown in FACS analysis and confocal microscopy of
co-cultured cells (Figure 3e).
Effects of WIF-1 downregulation in fibroblasts on tyrosinase
expression and melanosome transfer
As fibroblasts are components of the dermis, the effects of
WIF-1 downregulation in cultured fibroblasts were examined
using a mixed-cell three-dimensional culture system, after
confirming that WIF-1 siRNA significantly (Po0.005) re-
duced the expression levels of WIF-1 mRNA and protein in
fibroblasts (Figure 4a). To keep the condition the same as the
WIF-1 downregulated keratinocytes (Figure 3b–e), the inserts
containing keratinocyte/melanocyte co-cultures were used
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for the study. Knockdown of WIF-1 significantly (Po0.005)
stimulated the expression levels of tyrosinase (Figure 4b).
Phosphorylation of GSK-3b, b-catenin, and NFATc2 was
significantly (Po0.05) reduced, whereas MITF expression
increased (Figure 4c). FACS analysis to examine melanosome
transfer to neighboring keratinocytes suggested that the
percentages of TYRP-1 and K14 double-positive cells were
significantly (Po0.001) increased following WIF-1 knock-
down (Figure 4d).
The effect of WIF-1 upregulation on melanogenesis and
melanosome transfer
The increased expression of WIF-1 was directly induced in the
monocultures of melanocytes, as well as co-cultures by the
treatment with recombinant humanWIF-1 (rhWIF-1; Figure 5a).
Tyrosinase expression was significantly (Po0.001) reduced
(Figure 5b) with MITF expression, whereas the phosphorylation
of GSK-3b, b-catenin, and NFATc2 was increased (Po0.05;
Figure 5c) in co-cultures. Reduced tyrosinase expression (Figure
5b) was also identified with decreased b-catenin and NFATc2
in the nuclear fraction (Figure 5d) of melanocyte monocultures.
FACS analysis suggested that the proportions of TYRP-1 and
K14 double-positive cells were significantly decreased
(Po0.005; Figure 5e).
Wnts in the skin of melasma patients
WIF-1 is a secreted antagonist of Wnt signaling (Hsieh et al.,
1999) that inhibits both the canonical and noncanonical Wnt
pathways. Our results revealed that the decreased expression
of WIF-1 in either keratinocytes or fibroblasts affected both
Wnt pathways (Figures 3d and 4c), which were reversed by
the WIF-1 overexpression (Figure 5c and d). Therefore, the
expression of canonical Wnts, Wnt-1 and Wnt-3A, as well as
noncanonical Wnts, Wnt-5A and Wnt-11, was compared
using real-time PCR in hyperpigmented and normally
pigmented skin of the same 13 patients with melasma. Levels
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Figure 1. Expression of Wnt inhibitory factor-1 (WIF-1) in the skin of patients with melasma. (a–c) Real time-PCR analysis of WIF-1 mRNA expression
in (a) hyperpigmented (L) and normally pigmented (N) skin specimens biopsied from 13 patients with melasma, (b) in corresponding paired sites, cheeks or
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healthy normal controls. *Po0.001. (d) Double staining of hyperpigmented (L) and normally pigmented (N) skin of melasma patients with anti-WIF-1 and
anti-K14 antibodies, which emit green and red fluorescence, respectively. Nuclei were counterstained with Hoechst 33258, which emits blue fluorescence.
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of Wnt-1 and Wnt-5A expression were significantly (Po0.05)
higher in the hyperpigmented skin, whereas levels of other
Wnts were not (Figure 6a). In fact, treatment with rhWnt-1
(Figure 6b) and rhWnt-5A (data not shown) significantly
(Po0.05) increased the expression levels of tyrosinase with
an activation of the canonical and the noncanonical path-
ways in cultured melanocytes.
DISCUSSION
This study reveals that decreased expression of WIF-1 is
involved in the hyperpigmented skin of patients with
melasma. As WIF-1 is an antagonist of Wnt signaling (Hsieh
et al., 1999), which regulates skin pigmentation, down-
regulation of WIF-1 could be expected to induce hyperpig-
mentation of the skin. In fact, WIF-1 mRNA levels are
significantly lower in hyperpigmented skin compared with
paired normally pigmented skin specimens from patients
with melasma (Figure 1a), along with staining intensity of
immunohistochemistry, using anti-WIF-1 antibody (Figure
1d). Although the biopsied site of normally pigmented skin is
not the forehead or the cheek, but the retroauricular area, the
effect of sunlight or site difference on the WIF-1 down-
regulation could be excluded, because the WIF-1 mRNA
levels did not reduce in paired skin specimens of the
corresponding sites and of the absence or presence of UV
irradiation from healthy control individuals (Figure 1b and c).
In addition, UV irradiation on cultured keratinocytes,
fibroblasts, and melanocytes did not induce any change in
WIF-1 expression levels (data not shown).
Expression of WIF-1 mRNA and protein, which was
examined in cellular components of the epidermis and the
dermis, was almost unrecognizable in melanocytes, whereas
they were easily detected in keratinocytes and fibroblasts
(Figure 2a and b), as previously reported (Cho et al., 2009;
Sasahara et al., 2009; Gudjonsson et al., 2010). The 12-O-
tetradecanoylphorbol-13-acetate contained in the melano-
cyte culture medium, which was also added into the media
for keratinocyte/melanocyte co-cultures, could affect the Wnt
signaling pathway through the PKC activation (Niedel et al.,
1983). However, the WIF-1 expression, with or without
12-O-tetradecanoylphorbol-13-acetate, was not changed in
melanocytes and keratinocytes, although it was increased in
the fibroblasts (Figure 2a and b). Therefore, we hypothesized
that the downregulation of WIF-1 function in keratinocytes
and/or fibroblasts, instead of melanocytes, may have an
impact on the skin hyperpigmentation. In fact, double
staining, which uses antibodies to WIF-1 and K14, suggests
a weaker staining of WIF-1 in the epidermal keratinocytes of
the hyperpigmented compared with that of the normally
pigmented skin specimens of melasma patients (Figure 1d).
Purification of melanocytes from keratinocyte/melanocyte
co-cultures required the treatment of enzymes, although that
from co-cultured fibroblasts did not. Therefore, keratinocyte/
melanocyte co-cultures were used to examine the effect of
WIF-1 downregulated keratinocytes or fibroblasts on normal
melanocytes. As established in the cell-to-cell interactions
between keratinocytes and melanocytes, the decreased
expression of WIF-1 in keratinocytes stimulates tyrosinase
b
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expression (Figure 3b) and melanosome transfer from co-
cultured normal melanocytes (Figure 3e). Regulation of
melanogenesis could also result from complex interactions
between melanogenic regulators in melanocytes and factors
derived from fibroblasts. Extracellular matrix proteins derived
from human dermal fibroblasts increase tyrosinase activity in
normal melanocytes (Hedley et al., 1996). The expression of
high levels of dickkopf 1 (DKK1), an inhibitor of the
canonical Wnt signaling pathway as a member of the
Dickkopf class of Wnt antagonists, has also been reported
in palmoplantar fibroblasts (Yamaguchi et al., 2004). In our
study, the effect of WIF-1 knockdown in fibroblasts was
examined using a three-dimensional collagen gel model
(Yamaguchi et al., 1999) to simulate real skin conditions.
WIF-1 knockdown in fibroblasts resulted in increases of both
tyrosinase expression (Figure 4b) and melanosome transfer to
keratinocytes (Figure 4d). Moreover, the result from the WIF-
1 knockdown in neighboring keratinocytes or fibroblasts is
reversed by treatment with rhWIF-1 in melanocyte mono-
cultures, as well as in keratinocyte/melanocyte co-cultures
(Figure 5b and e), suggesting the significance of down-
regulating WIF-1 function on hyperpigmentation.
WIF-1 belongs to the sFRP class of Wnt antagonists, which
can inhibit both the canonical and the noncanonical Wnt
pathways. In this study, the decreased expression of WIF-1,
either in keratinocytes (Figure 3c) or fibroblasts (Figure 4c),
reduces phosphorylation of GSK-3b and b-catenin, which
results in translocation of b-catenin to nucleus (Figure 3d).
These results indicate an involvement of the canonical Wnt/
b-catenin pathway with stimulating transcription of target
genes. Increase in MITF expression also supports the
involvement of the canonical pathway (Schepsky et al.,
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2006). The WIF-1 knockdown in either keratinocytes or
fibroblasts also increases the dephosphorylation of NFATc2,
which results in the translocation of NFATc2 to nucleus
(Figure 3d) that indicates the involvement of the noncanoni-
cal pathway with stimulating transcription of target genes.
Although PKC activation responds to calcium signals
(Sheldahl et al., 1999) as does NFATc2 (Murphy and Hughes,
2002; Saneyoshi et al., 2002), and PKC-z (San-Antonio et al.,
2002) and PKC-y (Granja et al., 2008) have interacted with
NFATc2, the phosphorylation of PKC-d/y is not significant
with the WIF-1 knockdown (Figures 3c and 4c). The result
that overexpression of WIF-1 by rhWIF-1 treatment reverses
the expression of both canonical and noncanonical signaling
molecules (Figure 5c) supports the notion thatWIF-1 exerts its
action through both the canonical and the noncanonical Wnt
pathways. WIF-1 overexpression decreased b-catenin and
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NFATc2 in nuclear fraction of melanocyte monocultures, as
well as in total cell lysates of keratinocyte/melanocyte co-
cultures (Figure 5c and d), suggesting the involvement of
same pathways in melanocytes.
WIF-1 is supposed to inhibit the Wnt action by direct
binding to Wnts. The increased Wnt-1 and Wnt-5A mRNA
levels in patients with melasma, who had reduced WIF-1
mRNA expression levels (Figure 6a), have supported the
interaction between WIF-1 and Wnts. Although Wnt expres-
sion in melanocytes by WIF-1 knockdown, either in
keratinocytes or in fibroblasts, was not examined, the
increased melanogenesis and the involved signaling path-
ways by the knockdown were the same as a result of the
treatment of cultured melanocytes with rhWnt-1 (Figure 6b)
and rhWnt-5A. Although it is uncertain how the reduced
WIF-1 expression in the neighboring keratinocytes or
fibroblasts could affect the melanogenesis in melanocytes,
paracrine effect could be expected, due to an unrecognizable
WIF-1 expression levels in melanocytes. Decreased WIF-1
expression in the neighboring keratinocytes or fibroblasts
could reduce WIF-1 binding to Wnts in melanocytes,
resulting in an increased Wnt expression and exerting the
action through the canonical and the noncanonical Wnt
pathways.
In summary, decreased expression of WIF-1, which may
occur in epidermal keratinocytes and dermal fibroblasts, is
implicated in melasma development via the stimulation of
melanogenesis and melanosome transfer through the upre-
gulation of Wnt, both canonical and noncanonical, signaling
pathway.
MATERIALS AND METHODS
Patients and healthy controls
A total of 13 female patients diagnosed with melasma between 35
and 58 years of age (mean 44 years) were included in the study. The
Institutional Review Board of Dongguk University Ilsan Hospital
approved this study, and the study was conducted according to the
Declaration of Helsinki Principles. After obtaining informed written
consent from participants, skin specimens were obtained by biopsy.
Pairs of normally pigmented and hyperpigmented samples were
taken from each participants for direct comparisons. As the location
of the hyperpigmented lesions was on the lateral side of the forehead
or the upper cheek and control skin was on the retroauricular area,
two corresponding sites were compared in the three age-matched
healthy females. Hyperpigmented skin, which was induced by
topical psoralen application, followed by a UVA irradiation twice a
week for 2 weeks in abdominal skin of another group of three
healthy males, was also compared.
Normal human keratinocyte, melanocyte, and fibroblast
cultures
Adult skin specimens obtained from Caesarean sections and
circumcisions were used to establish cells in culture.
For keratinocyte culture, individual epidermal cells were
suspended in EpiLife Medium (catalog number M-EPI-500-CA;
Invitrogen, Carlsbad, CA) supplemented with bovine pituitary
extract, bovine insulin, hydrocortisone, human EGF, and bovine
transferrin (catalog number S-001-5; Invitrogen). Keratinocytes from
passages 3 or 4 were used in these experiments. For melanocytes,
individual epidermal cells were suspended in Medium 254 (Invitro-
gen) supplemented with bovine pituitary extract, fetal bovine serum,
bovine insulin, hydrocortisone, basic fibroblast growth factor,
bovine transferrin, heparin, and phorbol 12-myristate 13-acetate
(Invitrogen). Melanocytes at passages between 7 and 15 were used.
For fibroblast culture, individual dermal cells were suspended in
DMEM (Gibco/BRL, Grand Island, NY) supplemented with 10% fetal
bovine serum (Gibco/BRL), 100Uml1 penicillin (Gibco/BRL), and
0.1mgml1 streptomycin (Gibco/BRL). Fibroblasts at passages
between 5 and 10 were used.
WIF-1 knockdown
For WIF-1 downregulation, keratinocytes or fibroblasts were
cultured in six-well plates (NUNC, Roskilde, Denmark) or 100mm
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Figure 6. Expression of Wnts in the skin of melasma patients. (a) Real-time
PCR analysis of Wnt-1 and Wnt-5A mRNA expression in hyperpigmented (L)
and in normally pigmented (N) skin specimens from 13 patients with
melasma. *Po0.05. (b) Western blot analysis of tyrosinase and Wnt signaling
factors in cultured melanocytes treated with recombinant human Wnt-1
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culture dishes (NUNC) and were transfected with 100 nM
or 500 nM siRNA for human WIF-1 or a negative control
(ON-TARGETplus SMARTpool or Non-targeting siRNA; Dharmacon
Research, Lafayette, CO) using the TransIT-siQUEST transfection
reagent (Mirus, PanVera, Madison, WI) according to the manufac-
turer’s protocol.
At 24 hours after the incubation, the transfected keratinocytes
were co-cultured with normal melanocytes for another 18 hours to
examine the effect of keratinocytes with WIF-1 knockdown on
melanogenesis and melanosome transfer.
For the effect of fibroblast with WIF-1 knockdown, three-
dimensional cultures were performed using the collagen gel model
(Yamaguchi et al., 1999): the transfected fibroblasts were suspended
in 1ml of collagen matrix (Invitrogen) and cultured in six-well culture
dishes (Corning, Corning, NY) for 1 hour. Then, normal keratinocytes
were cultured onto BioCoat cell culture inserts (Corning) for 24 hours,
before adding normal melanocytes onto the same inserts.
Treatment with rhWIF-1 or rhWnt-1
For the overexpression of WIF-1 or Wnt-1, melanocytes and/or
keratinocytes were simultaneously treated with or without
50 ngml1 rhWIF-1 (R&D Systems, Minneapolis, MN) or Wnt-1
(BioVision, Milpitas, CA) for 1 or 3 hours.
Nuclear protein extraction
Nuclear protein fraction was purified from melanocyte monocultures
or keratinocyte/melanocyte co-cultures, using the NE-PER Nuclear
and Cytoplasmic Extraction Reagents kit (Thermo, Rockford, IL). The
protein concentration of the lysate was measured using bicincho-
ninic acid protein assay kit (Thermo).
Real-time PCR
Levels of WIF-1, Wnt-1, and Wnt-5A mRNAs were quantitated by
real-time PCR using the Light Cycler real-time PCR (Roche,
Mannheim, Germany). Their relative amounts were calculated using
the ratio of each mRNA relative to the amount of glyceraldehyde-3-
phosphate dehydrogenase (GAPDH). The primers used and probes
were as follows: WIF-1 (No. HS00183662-m1; designed using
Applied Biosystems software, Foster City, CA); Wnt-1 50-CTCAT
GAACCTTCACAACAACGA-30 (forward) and 50-ATCCCGTGGCAC
TTGCA-30 (reverse); Wnt-5A 50-GACCACATGCAGTACATCGGA
GAAG-30 (forward) and 50-TCCACCTTCGATGTCGGAATTG-30
(reverse); GAPDH 50-TCCACTGGCGTCTTCACC-30 (forward) and
50-GGCAGAGATGATGACCCTTT-30 (reverse).
Western blot analysis
Equal amounts of extracted proteins (20 mg) were resolved and
transferred to nitrocellulose membranes. The membranes were
incubated with antibodies to b-catenin, phospho-b-catenin, GSK-
3b, phospho-GSK3b, JNK, phospho-JNK, PKC-d/y, phospho-PKC-d/
y, WIF-1, and NFATc2 (rabbit polyclonal; Cell Signaling Technol-
ogy, Beverly, MA), phospho-NFATc2, MITF (rabbit polyclonal; Santa
Cruz Biotechnology, Santa Cruz, CA), tyrosinase (goat polyclonal;
Santa Cruz Biotechnology), and Wnt-1 (rabbit polyclonal; Epitomics,
Burlingame, CA). After incubating with appropriate anti-mouse or
anti-rabbit horseradish peroxidase–conjugated antibodies (Thermo)
or with anti-goat horseradish peroxidase–conjugated antibody (Santa
Cruz Biotechnology) and an enhanced chemiluminescence solution
(Thermo), the signals were captured on an Image Reader (LAS-3000;
Fuji Photo Film, Tokyo, Japan). To monitor the amount of protein
loaded in each lane, the membranes were reprobed with a mouse
monoclonal anti-b-actin antibody (Sigma, St Louis, MO) and were
processed as described above. The protein bands were then
analyzed by densitometry.
Immunohistochemistry
Epidermal specimens were fixed in 4% paraformaldehyde, and were
then dehydrated and embedded in paraffin. After deparaffinization,
the sections were pretreated with a citric acid solution (100mM
citrate, pH 6.0) and 0.5% Triton X-100.
After blocking with 3% BSA, epidermal sections were incubated
with anti-WIF-1 (1:100 dilution; rabbit polyclonal; Santa Cruz
Biotechnology) and K14 (1:100 dilution; mouse monoclonal; Santa
Cruz Biotechnology) antibodies for primary antibodies. After staining
with Alexa Fluor–labeled goat anti-rabbit IgG (1:200 dilution; 488;
Molecular Probes, Eugene, OR) and Alexa Fluor–labeled goat anti-
mouse IgG (1:200 dilution; 594; Molecular Probes), the stained cells
were observed, using a fluorescence microscope (Dp Manager 2.1;
Olympus Optical, Tokyo, Japan).
Melanosome transfer
Flow cytometry analysis was performed as described previously
(Lin et al., 2008). Briefly, the cells were fixed with 2% paraformal-
dehyde, and incubated with both FITC-conjugated goat anti-TYRP-1
(1mg per 1 106 cells; Santa Cruz Biotechnology) and phycoery-
thrin-conjugated mouse anti-K14 (1:10; BD Biosciences, San Jose,
CA). Labeled cells were analyzed with a Cytomics FC500 flow
cytometer (Beckman Coulter, Hialeah, FL) using CXP software
(Beckman Coulter). Melanosome transfer efficacy was determined as
the number of K14 and TYRP-1 double-positive cells divided by the
total number of K14-positive cells.
For immunofluorescence study, the cultured cells were fixed
with a 4% paraformaldehyde solution and were pretreated with
0.2% of Triton X-100. The cells were incubated with anti-
TYRP-1 antibody (1:200 dilution; goat polyclonal; Santa Cruz
Biotechnology) and K14 (1:200 dilution; Santa Cruz Biotechnology),
and then with Alexa Fluor–labeled donkey anti-goat IgG
(1:200 dilution; Molecular Probes) as well as Alexa Fluor–labeled
goat anti-mouse IgG (1:200 dilution; Molecular Probes). Stained
cells were observed using a Zeiss LSM 510 confocal fluorescence
microscope (Oberkochen, Germany). For quantitative analysis of
K14 and TYRP-1 double-positive cells, 10 random fields were
photographed.
Statistical analysis
Statistical significance was assessed using analysis of variance tests.
A P-value of o0.05 is considered statistically significant. All results
are presented as means±SD of the combined data from three or five
independent experiments.
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